Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by Moneyclipon Feb 12, 2007 8:39pm
216 Views
Post# 12221220

RE: news

RE: newsGrandaddy of Stem Cell conferences should result in additional US investment interest and profile. Yes just another conference but it is THE conference, cumulative effect of these developments not to be denied. We are running up to phase IIa results in March, if they are positive as expected we will never be under a dollar again. The runnup we have experienced is a direct result of this series of conferences. Considering the area we are in we have a bargain basement valuation compared to US couterparts. From the todays release; About Stem Cell Summit: With close to 300 participants, this two day conference will be the largest gathering of stem cell company executives, scientists, investors and physicians worldwide that is focused on the commercialization of stem cell products. Website: www.stemcellsummit.com.
Bullboard Posts